Literature DB >> 15473104

Cognitive functioning predicts outpatient service utilization in schizophrenia.

Susan R McGurk1, Kim T Mueser, David Walling, Philip D Harvey, Herbert Y Meltzer.   

Abstract

Aim of the study was to evaluate the cognitive and symptom predictors of outpatient service utilization in schizophrenia. The relationships between cognitive functioning (verbal learning and memory, executive functions), symptoms (positive symptoms, negative symptoms), and outpatient service utilization (case management, medication monitoring), were examined in 20 patients receiving outpatient services at a psychosocial clubhouse over a 12-month period. Executive functions, as measured on the Wisconsin Card Sorting Test (WCST), were the only significant predictor of outpatient service utilization, accounting for over 20% of the variance in total outpatient services used, with greater impairment associated with higher service utilization. Specifically, poorer performance on the WCST was associated with delivery of more case management services, but not medication management services. More case management services may be required to compensate for impairments in executive functioning in patients with schizophrenia.

Entities:  

Mesh:

Year:  2004        PMID: 15473104     DOI: 10.1023/b:mhsr.0000036491.58918.71

Source DB:  PubMed          Journal:  Ment Health Serv Res        ISSN: 1522-3434


  13 in total

1.  Cognitive function and competitive employment in schizophrenia: relative contribution of insight and psychopathology.

Authors:  Michela Giugiario; Barbara Crivelli; Cinzia Mingrone; Cristiana Montemagni; Mara Scalese; Monica Sigaudo; Giuseppe Rocca; Paola Rocca
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2011-03-31       Impact factor: 4.328

Review 2.  Neurocognition: clinical and functional outcomes in schizophrenia.

Authors:  Martin Lepage; Michael Bodnar; Christopher R Bowie
Journal:  Can J Psychiatry       Date:  2014-01       Impact factor: 4.356

3.  Neurocognitive insight, treatment utilization, and cognitive training outcomes in schizophrenia.

Authors:  Cynthia Z Burton; Elizabeth W Twamley
Journal:  Schizophr Res       Date:  2014-12-18       Impact factor: 4.939

Review 4.  Recent advances in treating cognitive impairment in schizophrenia.

Authors:  Cherrie Galletly
Journal:  Psychopharmacology (Berl)       Date:  2008-09-03       Impact factor: 4.530

5.  Incidence and documentation of cognitive impairment among older adults with severe mental illness in a community mental health setting.

Authors:  R Scott Mackin; Patricia A Areán
Journal:  Am J Geriatr Psychiatry       Date:  2009-01       Impact factor: 4.105

6.  A comparison of remediation techniques on the Wisconsin Card Sorting Test in schizophrenia.

Authors:  Jimmy Choi; Matthew M Kurtz
Journal:  Schizophr Res       Date:  2008-10-19       Impact factor: 4.939

7.  Comparison of haloperidol, risperidone, sertindole, and modafinil to reverse an attentional set-shifting impairment following subchronic PCP administration in the rat--a back translational study.

Authors:  Pascal Goetghebeur; Rebecca Dias
Journal:  Psychopharmacology (Berl)       Date:  2008-04-08       Impact factor: 4.530

8.  Behavioural and molecular endophenotypes in psychotic disorders reveal heritable abnormalities in glutamatergic neurotransmission.

Authors:  L Scoriels; R M Salek; E Goodby; D Grainger; A M Dean; J A West; J L Griffin; J Suckling; P J Nathan; B R Lennox; G K Murray; E T Bullmore; P B Jones
Journal:  Transl Psychiatry       Date:  2015-03-31       Impact factor: 6.222

9.  Effectiveness and cost-effectiveness of cognitive adaptation training as a nursing intervention in long-term residential patients with severe mental illness: study protocol for a randomized controlled trial.

Authors:  Annemarie Pm Stiekema; Piotr J Quee; Marian Dethmers; Edwin R van den Heuvel; Jeroen E Redmeijer; Kees Rietberg; A Dennis Stant; Marte Swart; Jaap van Weeghel; André Aleman; Dawn I Velligan; Robert A Schoevers; Richard Bruggeman; Lisette van der Meer
Journal:  Trials       Date:  2015-02-12       Impact factor: 2.279

10.  Cognitive deficits and functional outcome in schizophrenia.

Authors:  Christopher R Bowie; Philip D Harvey
Journal:  Neuropsychiatr Dis Treat       Date:  2006-12       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.